Consensus ESG Ratings
Member Sign In
ESG News For HARADA INDUSTRY CO.,LTD.
These sites contributed news to this page:
-
BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy
Results from the global, Phase 3 RATIONALE 302 trial showed TEVIMBRA prolonged the survival of patients who received prior systemic treatment compared to chemotherapyApproval represents the first indication in the U.S. for TEVIMBRA